- Filed
- Apr 30, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Mar 31, 2025 | 227M sh |
| Long Term Debt | Q1 2025 · Mar 31, 2025 | $5.57B |
| Long Term Debt | Q1 2025 · Dec 31, 2024 | $4.88B |
| Short Term Debt | Q1 2025 · Mar 31, 2025 | $13M |
| Short Term Debt | Q1 2025 · Dec 31, 2024 | $7M |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $63M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $88M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.83B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.27B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $6.93B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $6.79B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $5.84B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.01B |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $14.05B |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $12.47B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $7.9B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $6.56B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $19.43B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $21.87B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 236.9M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $149M |
| Dividends Paid | Q1 2025 · Mar 31, 2024 | $153M |
| Capex restated | Q1 2025 · Mar 31, 2024 | $252M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$60M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.69 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.70 |
| Sga Expense restated | Q1 2025 · Mar 31, 2024 | $850M |
| Net Income | Q1 2025 · Mar 31, 2024 | $400M |
| Operating Income restated | Q1 2025 · Mar 31, 2024 | $666M |
| Cost Of Revenue restated | Q1 2025 · Mar 31, 2024 | $2.21B |
| Revenue restated | Q1 2025 · Mar 31, 2024 | $3.85B |